Business
Ikonisys Announces the Postponement of the Publication of Its 2024 Annual Financial Report
PARIS, April 25, 2025--Regulatory News: ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis laboratories, today announces the postponement of the publication of its 2024 annual financial report, initially scheduled on April 30, 2025, to no later than May 31, 2025.
About this update from Ikonisys Sa
[{"type":"text","content":"PARIS, April 25, 2025--(BUSINESS WIRE)--Regulatory News:","length":56,"tagName":"p"},{"type":"text","content":"ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis laboratories, today announces the postponement of the publication of its 2024 annual financial report, initially scheduled on April 30, 2025, to no later than May 31, 2025.","length":369,"tagName":"p"},{"type":"text","content":"This postponement is due to the inclusion for the first time of the accounts of Hospitex International in the Group’s consolidated financial statement. Hospitex joined the Group in 2024 and its inclusion represents a major step in the Group’s growth and transformation. This consolidation process requires thorough integration work to ensure a fair, accurate and consistent presentation of the Group’s financial position.","length":421,"tagName":"p"},{"type":"text","content":"Ikonisys remains committed to delivering high-quality consolidated financial statements that reflect both continuity with past periods and transparency regarding the Group’s new structure. The additional time will allow the Company to finalize this process with the rigor and precision expected by its stakeholders.","length":315,"tagName":"p"},{"type":"text","content":"About ALIKO SCIENTIFIC (Ikonisys SA)","length":36,"tagName":"p"},{"type":"text","content":"Headquartered in Paris, ALIKO SCIENTIFIC is the parent company of an international ecosystem of businesses dedicated to advancing oncology diagnostics. Listed on Euronext Growth Paris under the ticker ALIKO, the company coordinates industrial, financial and research activities through its subsidiaries: Ikonisys Inc. (USA) and Hospitex International (Italy). ALIKO SCIENTIFIC's mission is to innovate cancer diagnosis by uniting cutting-edge technologies, resources, and strategic investments to create a global center of excellence in oncology.","length":550,"tagName":"p"},{"type":"text","content":"For more information, visit: www.alikoscientific.com","length":52,"tagName":"p"},{"type":"text","content":"About IKONISYS","length":14,"tagName":"p"},{"type":"text","content":"Ikonisys is a global leader in automated diagnostics, specializing in fluorescence in situ hybridization (FISH) a...